Latest Findings: Ashwagandha Extract Reduces Chemotherapy Side Effects in Clinical Trial

Keywords: Ashwagandha Extract, Chemotherapy Side Effects, Withanolides, Quality of Life, Adaptogen, Blue Eyes Biotech

Title: Latest Findings: Ashwagandha Extract Reduces Chemotherapy Side Effects in Clinical Trial

Meta Description: Latest findings show Ashwagandha Extract reduces chemotherapy side effects. Blue Eyes Biotech supplies high-withanolide Ashwagandha for oncology support.

Article:

The application of adaptogenic herbs in oncology support has been strengthened by a 2024 clinical trial published in Integrative Cancer

Therapies. The study found that breast cancer patients undergoing chemotherapy who received a standardized Ashwagandha

(Withania somnifera) extract experienced significantly less chemotherapy-induced fatigue, better maintained their quality of life,

and showed a more favorable hematological profile compared to the placebo group. The researchers attributed these benefits to the

withanolides present in Ashwagandha, which help modulate the stress response and support cellular energy production. Blue Eyes

Biotech CO., Ltd. provides a high-potency Ashwagandha Extract, standardized to 10% withanolides, to help translate these clinical benefits

into accessible nutraceutical products. Our extract is produced from the root, which contains the highest concentration of active

withanolides, and is tested for heavy metals and other contaminants to ensure patient safety. For companies developing supportive care

supplements for cancer patients, managing side effects is a primary concern. Blue Eyes Biotech offers an ingredient with direct clinical

evidence for this purpose. Our technical data includes information on the specific withanolide profile, ensuring consistency with the extract

used in the research. By formulating with our Ashwagandha Extract, brands can create products that directly address the debilitating

fatigue and stress associated with chemotherapy, providing tangible support to patients during a challenging time and filling a crucial gap

in the market. Learn more at www.blueeyes-bio.com.